![]() |
|||
![]() |
|||
![]() |
Acute
Leukaemia
To see 'ALWP Updates' written for the EBMT News click
here V Rocha, M Labopin, E Gluckman. Umbilical cord blood for transplantation in adults. NEJM. 352:936-7, 2005 Aoudjhane M, Labopin M, Gorin NC, Shimoni A, Ruutu T, Kolb HJ, Frassoni F, Boiron JM, Yin JL, Finke J, Shouten H, Blaise D, Falda M, Fauser AA, Esteve J, Polge E, Slavin S, Niederwieser D, Nagler A, Rocha V; Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia. 2005 Dec;19(12):2304-12. Garderet L, Labopin M, Gorin NC, Polge E, Baruchel A, Meloni G, Ortega J, Vossen J, Bunjes D, Leverger G, Blaise D, Ferrant A, Brune M, Dore E, Gadner H, Zintl F, Yaniv I, Dini G, Frassoni F. Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT). Blood. 2005 Jan 1;105(1):405-9. Ruutu T, Corradini P, Gratwohl A, Holler E, Apperley J, Dini G, Rocha V, Schmitz N, Socie G, Niederwieser D. Use of intratecathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2005 ;35(2):121-4 Vanderson Rocha, MD, PhD; Myriam Labopin, MS,MD; Guillermo Sanz, MD; William Arcese MD, Rainer Schwerdtfeg, MD, Alberto Bosi MD, Niels Jacobsen MD, Tapani Ruutu MD, Marcos de Lima MD,Jurgen Finke MD, Francesco Frassoni MD, Eliane Gluckman, MD and other members of the Acute Leukemia Working Party of EBMT and Eurocord-Netcord registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. New England Journal of Medicine. 2004; 351:2276-85 Bhawna Sirohi, Ray Powles, Claudius Rudin, Samar Kulkarni, Francesco Frassoni, Andrea Baciagalupo, Seema Singhal, Myriam Labopin, Mauricette Michallet, Didier Blaise, Josy Reiffers, Giovanna Meloni, Bernard Rio, Jennifer Treleaven, Clive Horton, Jayesh Mehta. Reassessing autotransplantation for acute myeloid leukaemia in first remission – a matched pair analysis of autologous marrow versus peripheral blood stem cells. Bone Marrow Transplant. 2004; 33(12):1209-14 Fouillard L, Labopin M, Meloni G, Polge E, Gorin NC, Frassoni F. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia. Haematologica. 2004; 89(1):107-8 Olle Ringdén, Myriam Labopin, Norbert-Claude Gorin, Katarina Le Blanc, Vanderson Rocha, Eliane Gluckman, Jules Reiffers, William Arcese, Jaak M. Vossen, Jean-Pierre Jouet, Catherine Cordonnier and Francesco Frassoni, for the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death. J Clin Oncol. 2004 Feb 1;22(3):416-23 Vanderson Rocha, MD, PhD; Myriam Labopin, MS,MD; Guillermo Sanz, MD; William Arcese MD, Rainer Schwerdtfeg, MD, Alberto Bosi MD, Niels Jacobsen MD, Tapani Ruutu MD, Marcos de Lima MD,Jurgen Finke MD, Francesco Frassoni MD, Eliane Gluckman, MD and other members of the Acute Leukemia Working Party of EBMT and Eurocord-Netcord registry. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. New England Journal of Medicine. 2004, Nov; 351(22):2265-75 Fouillard L, Labopin M, Meloni G, Polge E, Gorin NC, Frassoni F. Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission. Blood 2003 Feb; 101(4):1611-9 Garderet L, Labopin M, Gorin NC, Polge E, Fouillard L,
Ehninger GE, Ringden O, Finke J, Tura S, Frassoni F. Patients
with acute lymphoblastic leukaemia allografted with a matched unrelated
donor may have a lower survival with a peripheral blood stem cell graft
compared to bone marrow. Bone Marrow Transplant 2003 Jan;31(1):23-9 Gorin NC;Labopin M;Rocha V;Arcese W;Beksac M;Gluckman E;Ringden O;Ruutu T;Reiffers J;Bandini G;Falda M;Zikos P;Willemze R;Frassoni F; Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow. Blood. 2003 Gorin NC, Labopin M, Polge E, Cordonnier C, Jouet JP, Michallet M, Blaise D, Reiffers J, Rio B, Milpied N, Frassoni F; Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation. Leukemia. 2003 Aug; 17(8):1596-9 Van Kempen-Harteveld ML, Belkacemi Y, Kal HB, Labopin
M, Frassoni F. Dose-effect
relationship for cataract induction after single-dose total body irradiation
and bone marrow transplantation for acute leukemia.
Int J Radiat Oncol Biol Phys 2002 Apr 1;52(5):1367-74 A Bosi, D Laszlo, M Labopin, E Gluckman, PE Alessandrino, F Locatelli, J Sierra and F Frassoni Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow transplantation (EBMT) of 170 cases. Journal of Clinical Oncology, 2001. V Rocha, M Labopin, E Gluckman, T Ruutu, W Arcese, J Reiffers,
A Iriondo, O Ringdén and F Frassoni on behalf of the Acute Leukemia
Working Party (ALWP) of the European Blood and Marrow Transplant (EBMT)
registry. The results of allogeneic transplant for acute myeloid leukaemia
can be consistently improved by increasing the bone marrow cell dose.
A European survey. Submitted O. Ringden, M Labopin, F Frassoni, GF Sanz, F Demeocq, HG Prentice, JY Cahn, T Barbui, G Meloni, UW Schaefer, J Reiffers, NC Gorin. Allogeneic bone marrow transplantation or second autograft in patients with acute leukemia who had relapse after an autograft. Bone Marrow transplantation 1999, 24: 389-396. Belkacemi Y, Labopin M, Vernant JP, Prentice H, Tichelli
A, De Witte T, Boogaerts M, Ernst P, Della Volpe A, Goldstone A, Jouet
JP, Verdonck L, Rio B, Locasciulli A, Ozsahin M, Gorin NC. Cataracts
following bone marrow transplantation conditioned with total body irradiation
in patients with acute leukemia in first remission. International
Journal of Radiotherapy and Biological Physics, 1998, 41 (3): 659-68. O. Ringden, M. Labopin, E. Gluckman, J. Reiffers, J.P.
Vernant, J.P. Jouet, Jl. Harrousseau, D. Fiere, A. Bacigalupo, F. Frassoni
and N.C. Gorin For the Acute Leukemia Working Party of the European Group
for Blood and Marrow Transplantation: Strong
antileukemic effect of chronic graft versus host disease in allogeneic
marrow transplant recipients having acute leukemia treated with methotrexate
and cyclosporine. Transplantation Proceedings 1997, 29: 733-34 F. Frassoni, M. Labopin, E. Gluckman, H.G. Prentice, J.P.
Vernant, F. Zwaan, A. Granena, G. Gahrton, T. De Witte, A. Gratwohl, J.
Reiffers and N.C. Gorin: Results
of allogeneic bone marrow transplantation for acute leukemia have improved
in Europe with time: a report of the acute leukemia working party of the
european group for blood and marrow transplantation (EBMT), Bone
Marrow Transplantation, 1996, 17, 13-18. O. Ringden, Jr Mentz, M. Labopin, J. Apperley, Nc. Gorin
and A. Gratwhol: for the acute and chronic leukemia working-parties of
the european group for blood and marrow transplantation (EBMT): the
highest leukemia-free-survival after allogeneic bone marrow transplantation
is seen in patients with grade 1 acute graft versus host disease.
Leukemia & Lymphoma, 1996, 24: 71-79 JY Cahn, M. Labopin and N C. Gorin: Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in elderly patients: a retrospective analysis of the European Bone Marrow Transplant Registry (EBMT). Blood. 1995 Jan 15;85(2):575-9 M. Labopin, N.C. Gorin: Autologous bone marrow transplantation
in acute myelocytic leukemia in Europe: the role of marrow purging.
Acute Leukemia IV, Prognostic factors, Büchner t al (Eds). Springer-Verlag,
Berlin Heidelberg, 1994, 673-680 P. Herve, M. Labopin, E. Plouvier, P. Palut, P. Tiberghien,
N.C. Gorin: Autologous
bone marrow transplantation for childhood acute myeloid leukemia: a European
survey. Bone Marrow Transpl. 1991;8 Suppl 1:76-9 N.C. Gorin, M. Labopin, G. Meloni, M. Korbling, A. Carella,
P. Herve, A. Brunett, V. Rizzoli, Ep Alessandrino, B.Bjorkstrand, A. Ferrant,
B. Lowenberg, P. Coser, B. Simonsson, W. Helbig, S. Brunet-Mauri, Lf Verdonck,
A. Iriondo, E. Polli, P. Colombat, Im Franklin, G. Souillet and R. Willemze:
Autologous
bone marrow transplantation for acute myeloblastic leukemia in Europe:
further evidence of the role of marrow purging by mafosfamide. Leukemia,
1991, 5, 10, 896-904
|
||
![]()
| What is the EBMT? | Related Meetings | Membership | Registry | Working Parties |
| Nurses Group | Directory | Transplant Guidelines | Corporate Sponsorship |
HOME | SITE MAP | RELATED LINKS | CONTACT US |